CD226 and cancer: NK cells, whether endogenous or allografted, recognize cancer cells (i) with downregulated MHC class I via inhibitory receptor disengagement and (ii) expressing stress-induced ligands, which bind NK activating receptors (e.g. NKG2D, DNAM-1)(6).